Sort
39,280 grants matching “leukemia”
Growth-Differentiation Factors in Organogenesis
$981,912Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$981,896Irving Lerner Weissman · Stanford University · R35 · FY2019 · CA
Regulation of innate lymphocyte function
$978,700Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Clinical Cancer Cytogenetics
$977,708Diane C Arthur · Basic Sciences · Z01 · FY2007 · CA
National Resource for Translational and Developmental Proteomics
$977,670Neil L Kelleher · Northwestern University · P41 · FY2019 · GM
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
$977,629David A Williams · Boston Children'S Hospital · U01 · FY2012 · AI
Bone Marrow Failure Clinical Research Center
$977,392Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · U54 · FY2006 · RR
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$976,228Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Studies of Occupational Cancer (Pesticides)
$975,974Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Molecular strategies for early detection and targeting of cancer
$975,945Tannishtha Reya · University Of California, San Diego · R35 · FY2021 · CA
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$975,365Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
CALGB STUDIES OF BREAST CANCER IN THE ELDERLY
$975,261University Of Chicago · U10 · FY2000 · CA
Beaumont Community Clinical Oncology Program
$975,009William Beaumont Hospital Research Inst · U10 · FY2002 · CA
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$974,850Joel S. Bader · Johns Hopkins University · U01 · FY2018 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$974,472Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping
$974,208Jing Zhou · Isoplexis, Inc. · R44 · FY2017 · CA
Mechanisms of Mammalian Epigenome Reprogramming
$974,032Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2021 · CA
Human natural killer cells: Advancing biology and clinical applications
$973,964Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2020 · CA
Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia
$973,478Carlo M Croce · Ohio State University · P01 · FY2010 · CA
New Paradigms for Targeting Truncal Driver Mutations
$972,607William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2018 · CA
Inhibition of p53 Tumor Suppressor Function by HTLV-I
$972,122John N. Brady · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
$971,850Jonah B. Sacha · Oregon Health & Science University · R01 · FY2023 · AI
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
$971,850Jonah B. Sacha · Oregon Health & Science University · R01 · FY2024 · AI
Development of small molecule inhibitor of Mcl-1 for cancer treatment
$971,831Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2011 · CA